KLRS Q4 2024 Earnings — Kalaris Therapeutics Inc Revenue & Financial Results | Market Cap Arena

KLRSKalaris Therapeutics Inc

$187M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$20M

Net Income

-$18M

EPS (Diluted)

$-3.64

QoQ Revenue Growth

NaN%

Balance Sheet

Total Assets

$119M

Total Liabilities

$5M

Stockholders' Equity

$113M

Cash & Equivalents

$118M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$20M	-$3M	-463.6%
Net Income	-$18M	-$3M	-426.3%